APO Research
Talk to an analyst

APO RESEARCH · REPORT

C-X-C Chemokine Receptor Type 4

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global C-X-C Chemokine Receptor Type 4 Industry Growth and Trends Forecast to 2032

19 December 2025112 pages

Choose your research edition.

Industry ResearchC-X-C Chemokine Receptor Type 4 Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal C-X-C Chemokine Receptor Type 4 Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal C-X-C Chemokine Receptor Type 4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C-X-C Chemokine Receptor Type 4 Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal C-X-C Chemokine Receptor Type 4 Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global C-X-C Chemokine Receptor Type 4 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for C-X-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for C-X-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C-X-C Chemokine Receptor Type 4 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the C-X-C Chemokine Receptor Type 4 market include Sanofi, Eli Lilly and Company, X4 Pharmaceuticals, Inc., Upsher-Smith Laboratories, Inc., TaiGen Biotechnology Co., Ltd., Polyphor Ltd., Pharis Biotec GmbH, NeED Pharma s.r.l. and GlycoMimetics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global C-X-C Chemokine Receptor Type 4 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The C-X-C Chemokine Receptor Type 4 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C-X-C Chemokine Receptor Type 4 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C-X-C Chemokine Receptor Type 4.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global C-X-C Chemokine Receptor Type 4 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

C-X-C Chemokine Receptor Type 4 Market by Company

Sanofi

Eli Lilly and Company

X4 Pharmaceuticals, Inc.

Upsher-Smith Laboratories, Inc.

TaiGen Biotechnology Co., Ltd.

Polyphor Ltd.

Pharis Biotec GmbH

NeED Pharma s.r.l.

GlycoMimetics, Inc.

Globavir Biosciences, Inc.

Bristol-Myers Squibb Company

BioLineRx, Ltd.

Biokine Therapeutics Ltd.

Anchor Therapeutics, Inc.

Ambrx, Inc.

AdAlta Pty Ltd.

C-X-C Chemokine Receptor Type 4 Segment by Type

HPH-112

GMI-1359

BL-8040

AM-3114

Others

C-X-C Chemokine Receptor Type 4 Segment by Application

Myocardial Infarction

Renal Cell Carcinoma

Stroke

Liver Cancer

Others

C-X-C Chemokine Receptor Type 4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-X-C Chemokine Receptor Type 4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-X-C Chemokine Receptor Type 4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-X-C Chemokine Receptor Type 4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of C-X-C Chemokine Receptor Type 4 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global C-X-C Chemokine Receptor Type 4 Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global C-X-C Chemokine Receptor Type 4 Market Size by Region (2021-2026) & (US$ Million) Table 3. Global C-X-C Chemokine Receptor Type 4 Market Share by Region (2021-2026) Table 4. Global C-X-C Chemokine Receptor Type 4 Market Size by Region (2027-2032) & (US$ Million) Table 5. Global C-X-C Chemokine Receptor Type 4 Market Share by Region (2027-2032) Table 6. Global C-X-C Chemokine Receptor Type 4 Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global C-X-C Chemokine Receptor Type 4 Market Size by Type (2021-2026) & (US$ Million) Table 8. Global C-X-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2026) Table 9. Global C-X-C Chemokine Receptor Type 4 Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global C-X-C Chemokine Receptor Type 4 Market Size Share Forecasted by Type (2027-2032) Table 11. North America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global C-X-C Chemokine Receptor Type 4 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global C-X-C Chemokine Receptor Type 4 Market Size by Application (2021-2026) & (US$ Million) Table 23. Global C-X-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2026) Table 24. Global C-X-C Chemokine Receptor Type 4 Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global C-X-C Chemokine Receptor Type 4 Market Size Share Forecasted by Application (2027-2032) Table 26. North America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. C-X-C Chemokine Receptor Type 4 Industry Trends Table 37. C-X-C Chemokine Receptor Type 4 Industry Drivers Table 38. C-X-C Chemokine Receptor Type 4 Industry Opportunities and Challenges Table 39. C-X-C Chemokine Receptor Type 4 Industry Restraints Table 40. Global C-X-C Chemokine Receptor Type 4 Revenue by Company (US$ Million) & (2021-2026) Table 41. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Company (2021-2026) Table 42. Global C-X-C Chemokine Receptor Type 4 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global C-X-C Chemokine Receptor Type 4 Key Company Headquarters & Area Served Table 44. Global C-X-C Chemokine Receptor Type 4 Company, Product Type & Application Table 45. Global C-X-C Chemokine Receptor Type 4 Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global C-X-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi C-X-C Chemokine Receptor Type 4 Product Portfolio Table 52. Sanofi Recent Development Table 53. Eli Lilly and Company Company Information Table 54. Eli Lilly and Company Business Overview Table 55. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product Portfolio Table 57. Eli Lilly and Company Recent Development Table 58. X4 Pharmaceuticals, Inc. Company Information Table 59. X4 Pharmaceuticals, Inc. Business Overview Table 60. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 62. X4 Pharmaceuticals, Inc. Recent Development Table 63. Upsher-Smith Laboratories, Inc. Company Information Table 64. Upsher-Smith Laboratories, Inc. Business Overview Table 65. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 67. Upsher-Smith Laboratories, Inc. Recent Development Table 68. TaiGen Biotechnology Co., Ltd. Company Information Table 69. TaiGen Biotechnology Co., Ltd. Business Overview Table 70. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 72. TaiGen Biotechnology Co., Ltd. Recent Development Table 73. Polyphor Ltd. Company Information Table 74. Polyphor Ltd. Business Overview Table 75. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 77. Polyphor Ltd. Recent Development Table 78. Pharis Biotec GmbH Company Information Table 79. Pharis Biotec GmbH Business Overview Table 80. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product Portfolio Table 82. Pharis Biotec GmbH Recent Development Table 83. NeED Pharma s.r.l. Company Information Table 84. NeED Pharma s.r.l. Business Overview Table 85. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 87. NeED Pharma s.r.l. Recent Development Table 88. GlycoMimetics, Inc. Company Information Table 89. GlycoMimetics, Inc. Business Overview Table 90. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 92. GlycoMimetics, Inc. Recent Development Table 93. Globavir Biosciences, Inc. Company Information Table 94. Globavir Biosciences, Inc. Business Overview Table 95. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 97. Globavir Biosciences, Inc. Recent Development Table 98. Bristol-Myers Squibb Company Company Information Table 99. Bristol-Myers Squibb Company Business Overview Table 100. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product Portfolio Table 102. Bristol-Myers Squibb Company Recent Development Table 103. BioLineRx, Ltd. Company Information Table 104. BioLineRx, Ltd. Business Overview Table 105. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 107. BioLineRx, Ltd. Recent Development Table 108. Biokine Therapeutics Ltd. Company Information Table 109. Biokine Therapeutics Ltd. Business Overview Table 110. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 112. Biokine Therapeutics Ltd. Recent Development Table 113. Anchor Therapeutics, Inc. Company Information Table 114. Anchor Therapeutics, Inc. Business Overview Table 115. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 117. Anchor Therapeutics, Inc. Recent Development Table 118. Ambrx, Inc. Company Information Table 119. Ambrx, Inc. Business Overview Table 120. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 122. Ambrx, Inc. Recent Development Table 123. AdAlta Pty Ltd. Company Information Table 124. AdAlta Pty Ltd. Business Overview Table 125. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio Table 127. AdAlta Pty Ltd. Recent Development Table 128. North America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 130. North America C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 131. North America C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America C-X-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 133. Europe C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 136. Europe C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe C-X-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 141. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 143. Latin America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 146. Latin America C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America C-X-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2026) Table 151. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. C-X-C Chemokine Receptor Type 4 Product Image Figure 3. Global C-X-C Chemokine Receptor Type 4 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global C-X-C Chemokine Receptor Type 4 Market Size (2021-2032) & (US$ Million) Figure 5. Global C-X-C Chemokine Receptor Type 4 Market Share by Region: 2025 VS 2032 Figure 6. Global C-X-C Chemokine Receptor Type 4 Market Share by Region (2021-2032) Figure 7. North America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. HPH-112 Image Figure 13. Global HPH-112 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. GMI-1359 Image Figure 15. Global GMI-1359 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. BL-8040 Image Figure 17. Global BL-8040 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. AM-3114 Image Figure 19. Global AM-3114 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global C-X-C Chemokine Receptor Type 4 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global C-X-C Chemokine Receptor Type 4 Market Share by Type 2025 VS 2032 Figure 24. North America C-X-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 25. Europe C-X-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 27. Latin America C-X-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Share by Type (2021-2032) Figure 29. Myocardial Infarction Image Figure 30. Global Myocardial Infarction Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Renal Cell Carcinoma Image Figure 32. Global Renal Cell Carcinoma Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Stroke Image Figure 34. Global Stroke Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Liver Cancer Image Figure 36. Global Liver Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global C-X-C Chemokine Receptor Type 4 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global C-X-C Chemokine Receptor Type 4 Market Share by Application 2025 VS 2032 Figure 41. North America C-X-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 42. Europe C-X-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 44. Latin America C-X-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 C-X-C Chemokine Receptor Type 4 Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America C-X-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America C-X-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 51. Europe C-X-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe C-X-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 54. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 57. Latin America C-X-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 60. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • HPH-112
  • GMI-1359
  • BL-8040
  • AM-3114
  • Others
Applications
  • Myocardial Infarction
  • Renal Cell Carcinoma
  • Stroke
  • Liver Cancer
  • Others
Companies covered
  • Sanofi
  • Eli Lilly and Company
  • X4 Pharmaceuticals, Inc.
  • Upsher-Smith Laboratories, Inc.
  • TaiGen Biotechnology Co., Ltd.
  • Polyphor Ltd.
  • Pharis Biotec GmbH
  • NeED Pharma s.r.l.
  • GlycoMimetics, Inc.
  • Globavir Biosciences, Inc.
  • Bristol-Myers Squibb Company
  • BioLineRx, Ltd.
  • Biokine Therapeutics Ltd.
  • Anchor Therapeutics, Inc.
  • Ambrx, Inc.
  • AdAlta Pty Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global C-X-C Chemokine Receptor Type 4 Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global C-X-C Chemokine Receptor Type 4 Market Size by Region (2021-2032)
  5. 1.4.1 Global C-X-C Chemokine Receptor Type 4 Market Size by Region (2021-2026)
  6. 1.4.2 Global C-X-C Chemokine Receptor Type 4 Market Size by Region (2027-2032)
  7. 1.5 Key Regions C-X-C Chemokine Receptor Type 4 Market Size (2021-2032)
  8. 1.5.1 North America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (2021-2032)
2 C-X-C Chemokine Receptor Type 4 Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 HPH-112
  3. 2.1.2 GMI-1359
  4. 2.1.3 BL-8040
  5. 2.1.4 AM-3114
  6. 2.1.5 Others
  7. 2.2 Global C-X-C Chemokine Receptor Type 4 Market Size by Type
  8. 2.2.1 Global C-X-C Chemokine Receptor Type 4 Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global C-X-C Chemokine Receptor Type 4 Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global C-X-C Chemokine Receptor Type 4 Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global C-X-C Chemokine Receptor Type 4 Market Size by Regions
  12. 2.3.1 North America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Type (2021-2026)
3 C-X-C Chemokine Receptor Type 4 Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Myocardial Infarction
  3. 3.1.2 Renal Cell Carcinoma
  4. 3.1.3 Stroke
  5. 3.1.4 Liver Cancer
  6. 3.1.5 Others
  7. 3.2 Global C-X-C Chemokine Receptor Type 4 Market Size by Application
  8. 3.2.1 Global C-X-C Chemokine Receptor Type 4 Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global C-X-C Chemokine Receptor Type 4 Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global C-X-C Chemokine Receptor Type 4 Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global C-X-C Chemokine Receptor Type 4 Market Size by Regions
  12. 3.3.1 North America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 C-X-C Chemokine Receptor Type 4 Industry Trends
  2. 4.2 C-X-C Chemokine Receptor Type 4 Industry Drivers
  3. 4.3 C-X-C Chemokine Receptor Type 4 Industry Opportunities and Challenges
  4. 4.4 C-X-C Chemokine Receptor Type 4 Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by C-X-C Chemokine Receptor Type 4 Revenue (2021-2026)
  2. 5.2 Global C-X-C Chemokine Receptor Type 4 Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global C-X-C Chemokine Receptor Type 4 Key Company Headquarters & Area Served
  4. 5.4 Global C-X-C Chemokine Receptor Type 4 Company, Product Type & Application
  5. 5.5 Global C-X-C Chemokine Receptor Type 4 Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global C-X-C Chemokine Receptor Type 4 Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 C-X-C Chemokine Receptor Type 4 Players Market Share by Revenue in 2025
  9. 5.6.3 2025 C-X-C Chemokine Receptor Type 4 Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi C-X-C Chemokine Receptor Type 4 Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 X4 Pharmaceuticals, Inc.
  14. 6.3.1 X4 Pharmaceuticals, Inc. Company Information
  15. 6.3.2 X4 Pharmaceuticals, Inc. Business Overview
  16. 6.3.3 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio
  18. 6.3.5 X4 Pharmaceuticals, Inc. Recent Developments
  19. 6.4 Upsher-Smith Laboratories, Inc.
  20. 6.4.1 Upsher-Smith Laboratories, Inc. Company Information
  21. 6.4.2 Upsher-Smith Laboratories, Inc. Business Overview
  22. 6.4.3 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio
  24. 6.4.5 Upsher-Smith Laboratories, Inc. Recent Developments
  25. 6.5 TaiGen Biotechnology Co., Ltd.
  26. 6.5.1 TaiGen Biotechnology Co., Ltd. Company Information
  27. 6.5.2 TaiGen Biotechnology Co., Ltd. Business Overview
  28. 6.5.3 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio
  30. 6.5.5 TaiGen Biotechnology Co., Ltd. Recent Developments
  31. 6.6 Polyphor Ltd.
  32. 6.6.1 Polyphor Ltd. Company Information
  33. 6.6.2 Polyphor Ltd. Business Overview
  34. 6.6.3 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio
  36. 6.6.5 Polyphor Ltd. Recent Developments
  37. 6.7 Pharis Biotec GmbH
  38. 6.7.1 Pharis Biotec GmbH Company Information
  39. 6.7.2 Pharis Biotec GmbH Business Overview
  40. 6.7.3 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Product Portfolio
  42. 6.7.5 Pharis Biotec GmbH Recent Developments
  43. 6.8 NeED Pharma s.r.l.
  44. 6.8.1 NeED Pharma s.r.l. Company Information
  45. 6.8.2 NeED Pharma s.r.l. Business Overview
  46. 6.8.3 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Product Portfolio
  48. 6.8.5 NeED Pharma s.r.l. Recent Developments
  49. 6.9 GlycoMimetics, Inc.
  50. 6.9.1 GlycoMimetics, Inc. Company Information
  51. 6.9.2 GlycoMimetics, Inc. Business Overview
  52. 6.9.3 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio
  54. 6.9.5 GlycoMimetics, Inc. Recent Developments
  55. 6.10 Globavir Biosciences, Inc.
  56. 6.10.1 Globavir Biosciences, Inc. Company Information
  57. 6.10.2 Globavir Biosciences, Inc. Business Overview
  58. 6.10.3 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio
  60. 6.10.5 Globavir Biosciences, Inc. Recent Developments
  61. 6.11 Bristol-Myers Squibb Company
  62. 6.11.1 Bristol-Myers Squibb Company Company Information
  63. 6.11.2 Bristol-Myers Squibb Company Business Overview
  64. 6.11.3 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Product Portfolio
  66. 6.11.5 Bristol-Myers Squibb Company Recent Developments
  67. 6.12 BioLineRx, Ltd.
  68. 6.12.1 BioLineRx, Ltd. Company Information
  69. 6.12.2 BioLineRx, Ltd. Business Overview
  70. 6.12.3 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio
  72. 6.12.5 BioLineRx, Ltd. Recent Developments
  73. 6.13 Biokine Therapeutics Ltd.
  74. 6.13.1 Biokine Therapeutics Ltd. Company Information
  75. 6.13.2 Biokine Therapeutics Ltd. Business Overview
  76. 6.13.3 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio
  78. 6.13.5 Biokine Therapeutics Ltd. Recent Developments
  79. 6.14 Anchor Therapeutics, Inc.
  80. 6.14.1 Anchor Therapeutics, Inc. Company Information
  81. 6.14.2 Anchor Therapeutics, Inc. Business Overview
  82. 6.14.3 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio
  84. 6.14.5 Anchor Therapeutics, Inc. Recent Developments
  85. 6.15 Ambrx, Inc.
  86. 6.15.1 Ambrx, Inc. Company Information
  87. 6.15.2 Ambrx, Inc. Business Overview
  88. 6.15.3 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Product Portfolio
  90. 6.15.5 Ambrx, Inc. Recent Developments
  91. 6.16 AdAlta Pty Ltd.
  92. 6.16.1 AdAlta Pty Ltd. Company Information
  93. 6.16.2 AdAlta Pty Ltd. Business Overview
  94. 6.16.3 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Product Portfolio
  96. 6.16.5 AdAlta Pty Ltd. Recent Developments
7 North America
  1. 7.1 North America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 7.3 North America C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 8.3 Europe C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 10.3 South America C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst